Amgen Stock Falls on Weight Loss Drug's Bone Density Loss Data
Omar Marqués | Light rocket | fake images Actions of amgen fell more than 7% on Tuesday as analysts analyzed…
amgen inc
Medicare publishes prices for the first 10 drugs subject to negotiations
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
What Wall Street is watching
Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…
These drugmakers are catching up to Eli Lilly and Novo Nordisk
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…
Fund manager of names in weight loss and biotechnology
Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…
Investors could see evidence in H2 of AI's assistance in drug discovery
As investors look to the future to imagine which industries are ripe to be reshaped and energized by artificial intelligence,…
AstraZeneca will increase its revenues and launch new drugs by 2030
Astrazeneca's logo appears at the 2021 World Artificial Intelligence Conference in Shanghai, China on July 7, 2021. Costofoto | Future…
FDA approves Amgen's small cell lung cancer treatment
Amgen's headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | fake images The Food and Drug Administration on Thursday…
Amgen scraps experimental weight-loss pill, moves forward with shot
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Amgen Soars on Progress in Weight-Loss Drugs, Novo Nordisk and Eli Lilly Fall
amgenShares rose more than 12% on Friday after the drugmaker revealed positive initial data on its experimental weight-loss shot. That…